ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,123Medicare Part D Prescriptions Filled, Including Refills

Rank: 228 out of 1006

$608K Total Retail Price of All Prescriptions

Rank: 150 out of 1006

448 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 5,543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 257 227 1 2
PRAVASTATIN SODIUM 191 153 2 15
SIMVASTATIN 187 163 3 1
FUROSEMIDE 180 157 4 6
METOPROLOL SUCCINATE 177 155 5 12
METOPROLOL TARTRATE 162 161 6 7
ATORVASTATIN CALCIUM 156 149 7 5
AMLODIPINE BESYLATE 149 132 8 4
ZOLPIDEM TARTRATE 143 101 9 14
BENAZEPRIL HCL 139 103 10 112
LISINOPRIL 134 118 11 3
METFORMIN HCL 127 94 12 10
TAMSULOSIN HCL 117 103 13 23
OMEPRAZOLE 117 72 13 9
PANTOPRAZOLE SODIUM 110 73 15 32
NEXIUM 108 83 16 28
CYMBALTA 99 28 17 41
ADVAIR DISKUS 89 71 18 37
FINASTERIDE 86 86 19 76
GABAPENTIN 81 50 20 20
DIOVAN HCT 76 76 21 60
SERTRALINE HCL 75 72 22 19
DIOVAN 73 69 23 16
TRAMADOL HCL 70 46 24 35
CELEBREX 70 62 24 90
SPIRIVA 67 40 26 48
HYDROCHLOROTHIAZIDE 65 51 27 11
LOVASTATIN 62 50 28 44
CARISOPRODOL 61 0 R 29 172
DOXAZOSIN MESYLATE 61 61 29 87
HYDROCODONE-ACETAMINOPHEN 60 48 S3 31 25
SINGULAIR 57 30 32 82
ACIPHEX 56 29 33 253
CRESTOR 54 47 34 18
JANUVIA 53 45 35 49
LIPITOR 53 47 35 47
CLOPIDOGREL 51 51 37 46
FAMOTIDINE 50 36 38 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.